Morgan Stanley (NYSE:MS) upgraded Sartorius AG (ETR:SATG) (SRT3:GR) (OTC: SARTF), a prominent player in the bioprocessing industry, from Equalweight to Overweight, while also increasing the price ...

The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: Financial ...

Tuesday, Sartorius AG (ETR:SATG) (SRT3:GR) (OTC: SARTF) stock remained under the scrutiny of Bernstein SocGen Group, as the firm reiterated its Underperform rating and a price target of EUR194.00.

EQS Preliminary announcement financial reports: SARTORIUS AG / Preliminary announcement on the disclosure of financial statements Sartorius AG: Preliminary announcement of the publication of ...

EQS-News: SARTORIUS AG / Key word (s): Dividend The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share (news with additional features) 07.02.2025 / 15:48 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CapEx for R&D and Infrastructure: EUR340 million, with a CapEx ratio of 12.2%. Sartorius AG (SARTF) achieved its reverse guidance for 2024, with both top-line and profitability meeting expectations.

Sartorius AG (OTCPK:SARTF) added ~13% in European trading on Tuesday, rallying the shares of its U.S. peers in the premarket after the German life sciences company posted preliminary financials ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck KGaA raises prospect of return to sales growth next year Franco-German lab supplies maker Sartorius AG on Thursday lowered its full year forecast for sales and adjusted earnings margin on ...